Modular sensor architecture for cell based biosensors
The present invention provides modular extracellular sensors, nucleic acids encoding such sensors, and cells expressing such sensors, and methods of employing such sensors and cells for detecting extracellular ligands. In certain embodiments, the extracellular sensors comprise a ligand binding domain, a transmembrane domain, a protease domain, a protease cleavage site, and a transcription factor. In other embodiments, a pair of extracellular receptors is provided where both receptors contain a ligand binding domain and transmembrane domain, and one receptor contains a protease cleavage site and a transcription factor and the other receptor contains a protease domain.
1. A composition comprising:
i) first and second exogenous sensors wherein said first exogenous sensor comprises:
a) a first ligand binding domain,
b) a transmembrane domain,
c) a protease cleavage site, and
d) a functional domain;
and wherein said second exogenous sensor comprises:
e) a second ligand binding domain,
f) a transmembrane domain, and
g) a protease domain; and
ii) a cell, wherein said first and second exogenous sensors are located in the cell membrane such that the first and second ligand binding domains are located outside said cell; and wherein said protease cleavage site and said functional domain are located inside said cell; and
wherein said first and second ligand binding domains bind the same ligand outside said cell, and
wherein said first and second exogenous sensors are configured such that said protease domain will cleave said protease cleavage site when said first and second ligand binding domains bind said same ligand outside said cell.
2. The composition of claim 1 , further comprising third and fourth exogenous sensors.
3. The composition of claim 2 , wherein
i) said third exogenous sensor comprises:
a) a third ligand binding domain,
b) a transmembrane domain,
c) a protease cleavage site, and
d) a functional domain;
and wherein said fourth exogenous sensor comprises:
e) a fourth ligand binding domain,
f) a transmembrane domain, and
g) a protease domain; and
ii) a cell, wherein said third and fourth exogenous sensors are located in the cell membrane such that the third and fourth ligand binding domains are located outside said cell; and wherein said protease cleavage site and said functional domain are located inside said cell; and
wherein said third and fourth ligand binding domains bind the same ligand outside said cell which ligand is a different ligand than the ligand bound by the first and second ligand binding domains, and
wherein said third and fourth exogenous sensors are configured such that said protease domain of the fourth exogenous sensor will cleave said protease cleavage site of the third exogenous sensor when said third and fourth ligand binding domains bind said same ligand outside said cell.
4. The composition of claim 1 , wherein said first exogenous sensor or said second exogenous sensor further comprises an extracellular spacer.
5. The composition of claim 3 , wherein said third exogenous sensor or said fourth exogenous sensor further comprises an extracellular spacer.
6. The composition of claim 1 , wherein said first exogenous extracellular or said second exogenous extracellular sensor further comprises an intracellular spacer that is one, two, three, four, five, or six amino acids in length.
7. The composition of claim 3 , wherein said third exogenous extracellular or said fourth exogenous extracellular sensor further comprises an intracellular spacer that is one, two, three, four, five, or six amino acids in length.
8. The composition of claim 1 , wherein said functional domain is a transcription factor.
9. The composition of claim 8 , further comprising a genetic construct, wherein said genetic construct is configured to express a gene in response to said transcription factor and said genetic construct is located in said cell.
10. The composition of claim 9 , wherein said gene is a reporter gene or a therapeutic gene.
11. A composition comprising:
i) first and second exogenous sensors wherein said first exogenous sensor comprises:
a) a first ligand binding domain, said ligand binding domain comprising an antibody that binds a ligand or a fragment of an antibody that binds a ligand;
b) a transmembrane domain,
c) a protease cleavage site, and
d) a functional domain;
and wherein said second exogenous sensor comprises:
e) a second ligand binding domain,
f) a transmembrane domain, and
g) a protease domain; and
ii) a cell, wherein said first and second exogenous sensors are located in the cell membrane such that the first and second ligand binding domains are located outside said cell; and wherein said protease cleavage site and said functional domain are located inside said cell; and
wherein said first and second ligand binding domains bind the same ligand outside said cell, and
wherein said first and second exogenous sensors are configured such that said protease domain will cleave said protease cleavage site when said first and second ligand binding domains bind said ligand outside said cell.
12. The composition of claim 11 , wherein said first ligand binding domain or said second ligand binding domain comprises a single chain variable fragment of an antibody (scFv).
13. The composition of claim 11 , wherein said first exogenous sensor or said second exogenous sensor further comprises an extracellular spacer.
14. The composition of claim 11 , wherein said first exogenous extracellular or said second exogenous extracellular sensor further comprises an intracellular spacer that is one, two, three, four, five, or six amino acids in length.
15. The composition of claim 11 , wherein said functional domain is a transcription factor.
16. The composition of claim 15 , further comprising a genetic construct, wherein said genetic construct is configured to express a gene in response to said transcription factor and said genetic construct is located in said cell.
17. A composition comprising:
i) first and second exogenous sensors wherein said first exogenous sensor comprises:
a) a first ligand binding domain, said ligand binding domain comprising a ligand binding domain of a cell surface receptor;
b) a transmembrane domain,
c) a protease cleavage site, and
d) a functional domain;
and wherein said second exogenous sensor comprises:
e) a second ligand binding domain,
f) a transmembrane domain, and
g) a protease domain; and
ii) a cell, wherein said first and second exogenous sensors are located in the cell membrane such that the first and second ligand binding domains are located outside said cell; and wherein said protease cleavage site and said functional domain are located inside said cell; and
wherein said first and second ligand binding domains bind the same ligand outside said cell, and
wherein said first and second exogenous sensors are configured such that said protease domain will cleave said protease cleavage site when said first and second ligand binding domains bind said ligand outside said cell.
18. The composition of claim 17 , wherein said cell surface receptor is selected from a group consisting of cytokine receptors, chemokine receptors, innate immune receptors, olfactory receptors, steroid hormone receptors, growth factor receptors, mutant receptors that occur in cancer, and neurotransmitter receptors.
19. The composition of claim 17 , wherein said functional domain is a transcription factor.
20. The composition of claim 19 , further comprising a genetic construct, wherein said genetic construct is configured to express a gene in response to said transcription factor and said genetic construct is located in said cell.